Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Multicenter evaluation of the addition of eltrombopag to immunosuppressive therapy for adults with severe aplastic anemia.
Shinn LT, Benitez LL, Perissinotti AJ, Reid JH, Buhlinger KM, van Deventer H, Barth D, Wagner CB, Zacholski K, Desai R, Soule A, Stump SE, Weis TM, Bixby D, Burke P, Pettit K, Marini BL. Shinn LT, et al. Among authors: zacholski k. Int J Hematol. 2023 Dec;118(6):682-689. doi: 10.1007/s12185-023-03670-3. Epub 2023 Oct 26. Int J Hematol. 2023. PMID: 37882977
Abbreviated venetoclax with decitabine or azacitidine in acute myeloid leukemia.
Bouligny IM, Murray G, Ho T, Doyel M, Patel T, Boron J, Tran V, Gor J, Hang Y, Alnimer Y, Zacholski K, Venn C, Wages NA, Grant S, Maher KR. Bouligny IM, et al. Among authors: zacholski k. Leuk Res. 2023 Nov;134:107370. doi: 10.1016/j.leukres.2023.107370. Epub 2023 Aug 16. Leuk Res. 2023. PMID: 37659346 No abstract available.
Venetoclax with Decitabine or Azacitidine in Relapsed or Refractory Acute Myeloid Leukemia.
Bouligny IM, Murray G, Ho T, Doyel M, Patel T, Boron J, Tran V, Gor J, Hang Y, Alnimer Y, Zacholski K, Venn C, Wages NA, Grant S, Maher KR. Bouligny IM, et al. Among authors: zacholski k. Res Sq [Preprint]. 2023 Jun 12:rs.3.rs-3015916. doi: 10.21203/rs.3.rs-3015916/v1. Res Sq. 2023. Update in: EJHaem. 2023 Feb 24;4(2):381-392. doi: 10.1002/jha2.663 PMID: 37398154 Free PMC article. Updated. Preprint. No abstract available.
FLT3-ITD Allelic Burden and Acute Promyelocytic Leukemia Risk Stratification.
Li AY, Kashanian SM, Hambley BC, Zacholski K, Duong VH, El Chaer F, Holtzman NG, Gojo I, Webster JA, Norsworthy KJ, Smith BD, DeZern AE, Levis MJ, Baer MR, Kamangar F, Ghiaur G, Emadi A. Li AY, et al. Among authors: zacholski k. Biology (Basel). 2021 Mar 21;10(3):243. doi: 10.3390/biology10030243. Biology (Basel). 2021. PMID: 33800974 Free PMC article.
Increased body mass index is a risk factor for acute promyelocytic leukemia.
Kashanian SM, Li AY, Mustafa Ali M, Sutherland ME, Duong VH, Hambley BC, Zacholski K, El Chaer F, Holtzman NG, Imran M, Patzke CL, Cornu J, Duffy A, Dezern AE, Gojo I, Norsworthy KJ, Levis MJ, Smith BD, Baer MR, Ghiaur G, Emadi A. Kashanian SM, et al. Among authors: zacholski k. EJHaem. 2021 Feb;2(1):33-39. doi: 10.1002/jha2.163. Epub 2021 Jan 6. EJHaem. 2021. PMID: 33693438 Free PMC article.
11 results